News from kalobios pharmaceuticals, inc

Jun 11, 2014, 14:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present at 9th Annual JMP Securities Healthcare Conference

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following investor conference: The...

May 21, 2014, 12:28 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present at Jefferies 2014 Global Healthcare and BBC Boston CEO Conferences

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following investor conferences:...

May 08, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Provides First Quarter 2014 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced financial results for the first quarter of 2014 and provided an update on its current...

May 06, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

Ted W. Love, M.D., Named Chairman of the Board of KaloBios

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company's board of directors has elected Ted W. Love, M.D., as the...

Apr 03, 2014, 19:30 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Upcoming Participation at Needham Healthcare Conference

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following upcoming investor...

Mar 13, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Fiscal Year 2013 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on corporate accomplishments in fiscal 2013 and key milestones for 2014 as...

Mar 10, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Upcoming Participation at ROTH and BioCentury's Future Leaders in the Biotech Industry Conferences

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following upcoming investor...

Feb 11, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company has begun treating patients in the Phase 2 expansion portion of...

Feb 05, 2014, 18:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Upcoming Webcasts and Conference Participation

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that David Pritchard, President and Chief Executive Officer, will be presenting...

Jan 29, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the completion of the randomized, double-blind placebo-controlled Phase 2...

Jan 13, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

Epidemiological Study on Ventilator-Associated Pneumonia Incidence Reported at Critical Care Congress, Announces KaloBios

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the presentation of epidemiological research sponsored by...

Jan 07, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Harry Lam, Ph.D. as Head of Manufacturing. Dr. Lam brings to...

Dec 10, 2013, 09:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced preliminary results of an ongoing multi-center Phase 1 study of KB004, an...

Dec 05, 2013, 17:07 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that the U.S. Patent and Trademark Office has issued a Notice of...

Nov 12, 2013, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Reports Third Quarter 2013 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) a biopharmaceutical company with a portfolio of patient-targeted, first-in-class, monoclonal...

Nov 07, 2013, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH

SOUTH SAN FRANCISCO, Calif., Nov. 7, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that data from its...

Oct 30, 2013, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

U.S. FDA Grants Orphan Drug Designation for KaloBios' KB001-A in Treatment of Cystic Fibrosis Patients

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the U.S. Food & Drug Administration (FDA) has granted the company orphan...

Oct 23, 2013, 16:10 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Elects Laurie Smaldone Alsup, M.D. to Board

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of Laurie Smaldone Alsup, M.D. to KaloBios' Board of...

Oct 01, 2013, 16:05 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

 KaloBios Pharmaceuticals, Inc. (KaloBios) (NASDAQ:KBIO) today announced the completion of its public offering of 8,625,000 shares...

Sep 30, 2013, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present at Leerink Swann Rare Disease Roundtable

KaloBios Pharmaceuticals (Nasdaq: KBIO) today announced that the company will present at the Leerink Swann Rare Disease Roundtable on October 2 at...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge